1. Coker Appiah L, Fei YF, Olsen M, Lindheim SR, Puccetti DM. Disparities in female pediatric, adolescent and young adult oncofertility: a needs assessment. Cancers. 2021;13(21):5419. [DOI:10.3390/cancers13215419] [PMID] []

2. van der Perk MM, Van der Kooi A-LL, Bos AM, Broer SL, Veening MA, van Leeuwen J, et al. Oncofertility perspectives for girls with cancer. Elsevier; 2022. p. 523-6. [DOI:10.1016/j.jpag.2022.03.005] [PMID]

3. Sigismondi C, Papaleo E, Viganò P, Vailati S, Candiani M, Ottolina J, et al. Fertility preservation in female cancer patients: a single center experience. Breast cancer. 2015;17:17.7.

4. Lange S, Tait D, Matthews M. Oncofertility: an emerging discipline in obstetrics and gynecology. Obstetrical & gynecological survey. 2013;68(8):582-93. [DOI:10.1097/OGX.0b013e31829d460d] [PMID]

5. Woodruff TK. The Oncofertility Consortium-addressing fertility in young people with cancer. Nature Reviews Clinical Oncology. 2010;7(8):466-75. [DOI:10.1038/nrclinonc.2010.81] [PMID] []

6. van der Perk MM, van der Kooi A-LL, van de Wetering MD, IJgosse IM, van Dulmen-Den Broeder E, Broer SL, et al. Oncofertility care for newly diagnosed girls with cancer in a national pediatric oncology setting, the first full year experience from the Princess Máxima Center, the PEARL study. PLoS One. 2021;16(3):e0246344. [DOI:10.1371/journal.pone.0246344] [PMID] []

7. Trudgen K, Ayensu-Coker L. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient. Current Opinion in Obstetrics and Gynecology. 2014;26(5):372-80 %@ 1040-872X. [DOI:10.1097/GCO.0000000000000107] [PMID]

8. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology. 2013;31(19):2500-10. [DOI:10.1200/JCO.2013.49.2678] [PMID] []

9. Levine J. Fertility preservation in children and adolescents with cancer. Minerva pediatrica. 2011;63(1):49-59.

10. Levine JM, Kelvin JF, Quinn GP, Gracia CR. Infertility in reproductive‐age female cancer survivors. Cancer. 2015;121(10):1532-9. [DOI:10.1002/cncr.29181] [PMID]

11. Coccia PF, Pappo AS, Altman J, Bhatia S, Borinstein SC, Flynn J, et al. Adolescent and young adult oncology, version 2.2014. Journal of the National Comprehensive Cancer Network. 2014;12(1):21-32. [DOI:10.6004/jnccn.2014.0004] [PMID]

12. Marklund A, Eloranta S, Wikander I, Kitlinski ML, Lood M, Nedstrand E, et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study. Human Reproduction. 2020;35(4):929-38. [DOI:10.1093/humrep/deaa029] [PMID] []

13. Fong SL, Laven J, Hakvoort-Cammel F, Schipper I, Visser J, Themmen A, et al. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone. Human Reproduction. 2009;24(4):982-90. [DOI:10.1093/humrep/den487] [PMID]

14. Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, et al. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertility and sterility. 2010;94(2):638-44. [DOI:10.1016/j.fertnstert.2009.03.045] [PMID]

15. Su HI, Sammel MD, Green J, Velders L, Stankiewicz C, Matro J, et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive‐aged breast cancer survivors. Cancer. 2010;116(3):592-9. [DOI:10.1002/cncr.24746] [PMID] []

16. Kim SS, Donnez J, Barri P, Pellicer A, Patrizio P, Rosenwaks Z, et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. Journal of assisted reproduction and genetics. 2012;29(6):465-8. [DOI:10.1007/s10815-012-9786-y] [PMID] []

17. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of clinical oncology. 2006;24(18):2917-31. [DOI:10.1200/JCO.2006.06.5888] [PMID]

18. Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. Human reproduction. 2014;29(9):1931-40 %@ 0268-1161. [DOI:10.1093/humrep/deu158] [PMID]

19. Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D. Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study. Human Reproduction. 2009;24(1):206-10. [DOI:10.1093/humrep/den337] [PMID]

20. Irtan S, Orbach D, Helfre S, Sarnacki S. Ovarian transposition in prepubescent and adolescent girls with cancer. The Lancet Oncology. 2013;14(13):e601-e8. [DOI:10.1016/S1470-2045(13)70288-2] [PMID]

21. Filippi F, Meazza C, Somigliana E, Podda M, Dallagiovanna C, Massimino M, et al. Fertility preservation in childhood and adolescent female tumor survivors. Fertility and Sterility. 2021;116(4):1087-95. [DOI:10.1016/j.fertnstert.2021.06.012] [PMID]

22. Mofarahe ZS, Novin MG, Jafarabadi M, Salehnia M, Noroozian M, Ghorbanmehr N. Effect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis. Iranian biomedical journal. 2015;19(4).

23. Kilic S, Pinarli F, Ozogul C, Tasdemir N, Naz Sarac G, Delibasi T. Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. Gynecological Endocrinology. 2013;30(2):135-40. [DOI:10.3109/09513590.2013.860127] [PMID]

24. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Human reproduction update. 2009;15(6):649-65. [DOI:10.1093/humupd/dmp021] [PMID] []

25. Donnez J, Dolmans M-M, Pellicer A, Diaz-Garcia C, Serrano MS, Schmidt KT, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertility and sterility. 2013;99(6):1503-13. [DOI:10.1016/j.fertnstert.2013.03.030] [PMID]

26. Stern C, Gook D, Hale L, Agresta F, Oldham J, Rozen G, et al. First reported clinical pregnancy following heterotopic grafting of cryopreserved ovarian tissue in a woman after a bilateral oophorectomy. Human Reproduction. 2013:det360. [DOI:10.1093/humrep/det360] [PMID]

27. Fathi R, Valojerdi MR, Salehnia M, Ebrahimi B, Yazdi RS. Ovarian Tissue Transplantation: Advantages, Disadvantages and Upcoming Challenges (A Review Article). Journal of Mazandaran University of Medical Sciences (JMUMS). 2014;24(113).

28. Borhani N, Manoochehri M, Gargari SS, Novin MG, Mansouri A, Omrani MD. Decreased Expression of Proapoptotic Genes Caspase-8-and BCL2-Associated Agonist of Cell Death (BAD) in Ovarian Cancer. Clinical Ovarian and Other Gynecologic Cancer. 2014;7(1):18-23. [DOI:10.1016/j.cogc.2014.12.004]

29. Kondapalli LA, Dillon KE, Sammel MD, Ray A, Prewitt M, Ginsberg JP, et al. Quality of life in female cancer survivors: is it related to ovarian reserve? Quality of Life Research. 2014;23(2):585-92. [DOI:10.1007/s11136-013-0473-y] [PMID] []

30. Fasano G, Moffa F, Dechène J, Englert Y, Demeestere I. Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation. Reprod Biol Endocrinol. 2011;9:150. [DOI:10.1186/1477-7827-9-150] [PMID] []

31. Revel A, Revel-Vilk S, Aizenman E, Porat-Katz A, Safran A, Ben-meir A, et al. At what age can human oocytes be obtained? Fertility and sterility. 2009;92(2):458-63. [DOI:10.1016/j.fertnstert.2008.07.013] [PMID]

32. Fadini R, Renzini MM, Dal Canto M, Epis A, Crippa M, Caliari I, et al. Oocyte in vitro maturation in normo-ovulatory women. Fertility and sterility. 2013;99(5):1162-9. [DOI:10.1016/j.fertnstert.2013.01.138] [PMID]

33. Prasath E, Chan M, Wong W, Lim C, Tharmalingam M, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Human Reproduction. 2014;29(2):276-8. [DOI:10.1093/humrep/det420] [PMID]

34. Donnez J, Dolmans M-M. Fertility preservation in women. Nature Reviews Endocrinology. 2013;9(12):735-49. [DOI:10.1038/nrendo.2013.205] [PMID]

35. Glazer TS, Schulte F. Barriers to oncofertility care among female adolescent cancer patients in Canada. Current Oncology. 2022;29(3):1583-93. [DOI:10.3390/curroncol29030133] [PMID] []

36. Assouline E, Crocchiolo R, Prebet T, Broussais F, Coso D, Gamerre M, et al. Impact of Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation on Women's Fertility. Clinical Lymphoma Myeloma and Leukemia. 2013;13(6):704-10. [DOI:10.1016/j.clml.2013.05.014] [PMID]

37. Louwé LA, ter Kuile MM, Hilders CG, Jenninga E, Tiemessen SM, Peters AA, et al. Oncologists' practice and attitudes regarding fertility preservation in female cancer patients: a pilot study in the Netherlands. Journal of Psychosomatic Obstetrics & Gynecology. 2013;34(3):129-32. [DOI:10.3109/0167482X.2013.821977] [PMID]

38. Forman EJ, Anders CK, Behera MA. A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertility and sterility. 2010;94(5):1652-6. [DOI:10.1016/j.fertnstert.2009.10.008] [PMID]

39. Mersereau JE, Goodman LR, Deal AM, Gorman JR, Whitcomb BW, Su HI. To preserve or not to preserve. Cancer. 2013;119(22):4044-50. [DOI:10.1002/cncr.28317] [PMID] []

40. Linkeviciute A, Boniolo G, Chiavari L, Peccatori FA. Fertility preservation in cancer patients: the global framework. Cancer treatment reviews. 2014;40(8):1019-27. [DOI:10.1016/j.ctrv.2014.06.001] [PMID]

41. Bastings L, Beerendonk C, Westphal J, Massuger L, Kaal S, Van Leeuwen F, et al. Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Human reproduction update. 2013;19(5):483-506. [DOI:10.1093/humupd/dmt020] [PMID]

42. Bockstaele L, Tsepelidis S, Dechene J, Englert Y, Demeestere I. Safety of ovarian tissue autotransplantation for cancer patients. Obstetrics and gynecology international. 2011;2012. [DOI:10.1155/2012/495142] [PMID] []

43. Dolmans M-M, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertility and sterility. 2013;99(6):1514-22. [DOI:10.1016/j.fertnstert.2013.03.027] [PMID]

44. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Human Reproduction. 2008;23(5):1007-13. [DOI:10.1093/humrep/den055] [PMID]

45. Rosendahl M, Andersen CY, Ernst E, Westergaard LG, Rasmussen PE, Loft A, et al. Ovarian Function After Removal of an Entire Ovary for Cryopreservation of Pieces of Cortex Before Gonadotoxic Treatment: A Follow-Up Study. Obstetrical & Gynecological Survey. 2009;64(2):109-10. [DOI:10.1097/01.ogx.0000345379.35992.e9]

46. Anderson R, Wallace W, Baird D. Ovarian cryopreservation for fertility preservation: indications and outcomes. Reproduction. 2008;136(6):681-9. [DOI:10.1530/REP-08-0097] [PMID]

47. Ayensu-Coker L, Bauman D, Lindheim S, Breech L. Fertility preservation in pediatric, adolescent and young adult female cancer patients. Pediatric endocrinology reviews: PER. 2012;10(1):174-87.